RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 132 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $31,000 | -85.0% | 14,302 | -87.0% | 0.00% | -90.9% |
| Q3 2019 | $206,000 | +9.6% | 110,394 | +53.1% | 0.01% | +10.0% |
| Q2 2019 | $188,000 | -46.0% | 72,108 | -46.8% | 0.01% | -50.0% |
| Q1 2019 | $348,000 | +109.6% | 135,438 | +87.8% | 0.02% | +66.7% |
| Q4 2018 | $166,000 | -28.1% | 72,108 | 0.0% | 0.01% | -7.7% |
| Q3 2018 | $231,000 | -34.7% | 72,108 | -32.1% | 0.01% | -79.4% |
| Q2 2013 | $354,000 | – | 106,135 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |